
Ep114: Chris Gibson on Industrializing Drug Discovery
The Long Run with Luke Timmerman
Is There a Right or Wrong Shareholder Perspective?
Chris: I keep it seems like a through line with the way you think about building this company. Luke, these are long term, strategic moves. And do you get grief from this from shareholders woer more focused on the quarter? Chris: There's not a right or wrong shareholder perspective. We're trying to attract the kind of people that are betting on the long run.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.